Watchlist Manager

Watchlist

Price: 2.15 CNY -1.38% Market Closed

Market Cap: ¥18.3B

	Sichuan Hebang Biotechnology Co Ltd SSE:603077	CN

Income Statement

Currency: CNY

	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	0	0	119	0	0	0	82	0	0	0	134	0	0	0	120	0	0	0	113	0	0	21	62	34	42	40	58	54	56	53	57	67	75	81	82	85	87	85	78	70	65	61	51	51	48	48	24	44	52	60	67	78	0	0
Revenue	1 527 N/A	1 326 -13%	1 738 +31%	1 040 -40%	1 341 +29%	1 428 +6%	1 603 +12%	1 659 +4%	1 871 +13%	1 979 +6%	2 186 +10%	2 282 +4%	2 628 +15%	2 757 +5%	2 863 +4%	3 043 +6%	2 954 -3%	3 206 +9%	3 463 +8%	3 722 +7%	4 041 +9%	4 399 +9%	4 738 +8%	4 961 +5%	5 625 +13%	5 990 +6%	6 009 +0%	6 285 +5%	6 154 -2%	6 200 +1%	5 969 -4%	5 565 -7%	5 351 -4%	5 115 -4%	5 261 +3%	5 892 +12%	6 758 +15%	8 485 +26%	9 987 +18%	11 409 +14%	13 517 +18%	13 353 -1%	13 039 -2%	12 347 -5%	9 651 -22%	8 980 -7%	8 824 -2%	8 429 -4%	9 582 +14%	9 203 -4%	8 547 -7%	8 274 -3%	7 620 -8%	7 660 +1%
Gross Profit
Cost of Revenue	(808)	(747)	(1 085)	(763)	(1 017)	(1 172)	(1 296)	(1 372)	(1 550)	(1 602)	(1 803)	(1 832)	(2 079)	(2 176)	(2 255)	(2 389)	(2 296)	(2 465)	(2 609)	(2 785)	(3 076)	(3 398)	(3 532)	(3 902)	(4 373)	(4 607)	(4 686)	(4 929)	(4 829)	(4 860)	(4 624)	(4 372)	(4 295)	(4 122)	(4 283)	(4 687)	(4 895)	(5 485)	(5 861)	(6 350)	(7 252)	(7 405)	(7 473)	(7 709)	(6 788)	(6 702)	(6 821)	(6 863)	(8 029)	(8 044)	(8 032)	(7 697)	(7 194)	(7 125)
Gross Profit	720 N/A	579 -20%	653 +13%	277 -57%	323 +17%	255 -21%	307 +20%	288 -6%	321 +11%	377 +17%	383 +2%	450 +18%	549 +22%	581 +6%	608 +5%	653 +7%	658 +1%	740 +12%	854 +15%	938 +10%	965 +3%	1 002 +4%	1 206 +20%	1 059 -12%	1 253 +18%	1 383 +10%	1 324 -4%	1 357 +3%	1 325 -2%	1 340 +1%	1 345 +0%	1 193 -11%	1 056 -11%	993 -6%	978 -2%	1 206 +23%	1 863 +55%	3 000 +61%	4 126 +38%	5 059 +23%	6 264 +24%	5 948 -5%	5 566 -6%	4 638 -17%	2 862 -38%	2 278 -20%	2 003 -12%	1 566 -22%	1 553 -1%	1 159 -25%	516 -56%	577 +12%	426 -26%	535 +26%
Operating Income
Operating Expenses	(142)	(133)	(189)	(131)	(158)	(161)	(197)	(188)	(193)	(209)	(235)	(276)	(272)	(308)	(315)	(351)	(421)	(445)	(461)	(418)	(440)	(463)	(597)	(557)	(577)	(611)	(717)	(816)	(817)	(815)	(701)	(676)	(680)	(627)	(457)	(366)	(301)	(326)	(478)	(486)	(623)	(732)	(1 054)	(951)	(843)	(689)	(571)	(559)	(541)	(588)	(558)	(631)	(647)	(634)
Selling, General & Administrative	(142)	(131)	(170)	(126)	(154)	(156)	(178)	(178)	(189)	(208)	(209)	(198)	(228)	(264)	(284)	(335)	(363)	(384)	(407)	(460)	(470)	(490)	(530)	(524)	(544)	(579)	(649)	(620)	(639)	(640)	(595)	(644)	(632)	(582)	(315)	(337)	(276)	(301)	(331)	(474)	(611)	(721)	(933)	(824)	(686)	(561)	(456)	(495)	(509)	(523)	(439)	(484)	(505)	(505)
R&D	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(4)	0	0	0	(25)	0	0	(7)	(35)	0	0	(6)	(6)	(25)	(34)	(38)	(8)	(40)	(40)	(41)	(10)	(38)	(36)	(33)	(10)	(33)	(34)	(34)	(35)	(69)	(69)	(72)	(24)	(47)	(44)	(41)	(9)	(27)	(24)	(20)
Depreciation & Amortization	0	0	(18)	0	0	0	(19)	0	0	0	(21)	0	0	0	(23)	0	0	0	(28)	0	0	0	(35)	0	0	0	(61)	0	0	0	(102)	0	0	0	(135)	0	0	0	(145)	0	0	0	(117)	0	0	0	(107)	0	0	0	(126)	0	0	0
Other Operating Expenses	0	(3)	(0)	(4)	(4)	(4)	(1)	(11)	(4)	(1)	(5)	(78)	(44)	(44)	(5)	(16)	(58)	(60)	(2)	42	30	34	4	(33)	(32)	(26)	(2)	(171)	(145)	(137)	4	8	(8)	(4)	2	8	11	8	9	21	23	22	31	(58)	(87)	(56)	16	(18)	11	(24)	16	(120)	(118)	(109)
Operating Income	578 N/A	445 -23%	464 +4%	147 -68%	165 +12%	95 -43%	110 +16%	100 -9%	127 +28%	168 +32%	148 -12%	174 +17%	276 +59%	273 -1%	293 +7%	303 +3%	237 -22%	296 +25%	393 +33%	520 +32%	526 +1%	540 +3%	609 +13%	502 -18%	676 +35%	772 +14%	607 -21%	541 -11%	508 -6%	525 +3%	644 +23%	517 -20%	376 -27%	367 -2%	521 +42%	839 +61%	1 563 +86%	2 674 +71%	3 648 +36%	4 574 +25%	5 641 +23%	5 216 -8%	4 512 -14%	3 688 -18%	2 019 -45%	1 590 -21%	1 432 -10%	1 006 -30%	1 011 +1%	570 -44%	(42) N/A	(54) -28%	(221) -307%	(99) +55%
Pre-Tax Income
Interest Income Expense	(85)	(78)	(80)	(41)	(48)	(38)	(39)	(43)	574	553	531	515	(115)	(99)	(74)	(73)	(60)	(75)	(54)	(24)	(13)	4	(12)	(53)	(69)	(63)	(56)	(53)	(46)	(73)	(54)	(113)	(106)	(89)	(87)	(64)	(82)	(78)	(60)	(37)	(18)	(7)	(2)	4	48	60	87	101	46	21	(21)	(33)	(34)	(41)
Non-Recurring Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8	0	8	0	(1)	(1)	(1)	(1)	(137)	0	(4)	(4)	(8)	(2)	(2)	(2)	7	9	9	9	3	(3)	(3)	34	(29)	37	37	1	23	1	1	(0)	1	2	2	2
Gain/Loss on Disposition of Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(0)	0	0	0	(0)	0	0	0	(0)	0	0	0	(0)	0	0	0
Total Other Income	0	0	6	6	6	6	0	0	0	1	1	1	1	1	63	71	82	83	23	16	3	4	0	(0)	1	(3)	2	0	1	4	1	(1)	(1)	(446)	(425)	(423)	(420)	22	(13)	(15)	(18)	(15)	(2)	(1)	(1)	(1)	(6)	(5)	(6)	(6)	(4)	(4)	(4)	(17)
Pre-Tax Income	493 N/A	368 -25%	390 +6%	112 -71%	123 +10%	63 -49%	71 +12%	57 -20%	701 +1 139%	722 +3%	679 -6%	690 +2%	163 -76%	175 +8%	282 +61%	301 +7%	259 -14%	303 +17%	370 +22%	511 +38%	524 +2%	548 +5%	596 +9%	449 -25%	608 +35%	705 +16%	416 -41%	489 +18%	459 -6%	452 -2%	584 +29%	401 -31%	267 -33%	(170) N/A	16 N/A	362 +2 189%	1 070 +196%	2 626 +145%	3 578 +36%	4 518 +26%	5 603 +24%	5 228 -7%	4 479 -14%	3 728 -17%	2 104 -44%	1 649 -22%	1 536 -7%	1 103 -28%	1 052 -5%	586 -44%	(66) N/A	(89) -35%	(256) -189%	(155) +40%
Net Income
Tax Provision	(74)	(52)	(55)	(15)	(15)	(6)	(6)	(2)	(5)	(7)	(8)	(11)	(28)	(31)	(44)	(49)	(40)	(48)	(48)	(70)	(71)	(73)	(91)	(71)	(104)	(118)	(118)	(125)	(118)	(121)	(77)	(58)	(33)	(2)	(13)	(63)	(171)	(371)	(552)	(683)	(844)	(785)	(668)	(581)	(331)	(259)	(257)	(179)	(189)	(125)	(5)	(2)	37	(35)
Income from Continuing Operations	419	316	335	97	108	57	64	54	696	715	672	679	135	144	239	252	219	255	322	442	453	475	505	377	504	587	298	364	341	330	507	343	234	(172)	3	298	899	2 255	3 027	3 835	4 758	4 443	3 810	3 147	1 773	1 390	1 279	924	864	460	(71)	(90)	(219)	(190)
Income to Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	3	7	5	(4)	(5)	(2)	2	12	18	31	35	65	62	46	49	10	29	31	25	38	25	14	(2)	(8)	(20)	(18)	(5)	(3)	14	16	8	5	(8)	(5)	25	102	105	110	93
Net Income	419 N/A	316 -25%	335 +6%	97 -71%	108 +11%	57 -47%	64 +14%	54 -16%	696 +1 180%	715 +3%	672 -6%	679 +1%	135 -80%	144 +7%	240 +66%	255 +6%	226 -11%	260 +15%	318 +22%	436 +37%	451 +3%	477 +6%	518 +9%	395 -24%	535 +35%	622 +16%	363 -42%	426 +17%	387 -9%	380 -2%	517 +36%	372 -28%	264 -29%	(147) N/A	41 N/A	323 +690%	913 +183%	2 252 +147%	3 018 +34%	3 815 +26%	4 741 +24%	4 438 -6%	3 807 -14%	3 161 -17%	1 789 -43%	1 398 -22%	1 283 -8%	916 -29%	859 -6%	486 -43%	31 -94%	14 -55%	(109) N/A	(97) +11%
EPS (Diluted)	0.06 N/A	0.05 -17%	0.07 +40%	0.02 -71%	0.02 N/A	0.01 -50%	0.01 N/A	0.01 N/A	0.11 +1 000%	0.11 N/A	0.1 -9%	0.11 +10%	0.02 -82%	0.02 N/A	0.03 +50%	0.03 N/A	0.03 N/A	0.04 +33%	0.04 N/A	0.05 +25%	0.11 +120%	0.06 -45%	0.06 N/A	0.06 N/A	0.07 +17%	0.08 +14%	0.04 -50%	0.05 +25%	0.04 -20%	0.04 N/A	0.06 +50%	0.05 -17%	0.04 -20%	-0.01 N/A	0 N/A	0.04 N/A	0.11 +175%	0.27 +145%	0.36 +33%	0.45 +25%	0.55 +22%	0.51 -7%	0.44 -14%	0.36 -18%	0.21 -42%	0.16 -24%	0.15 -6%	0.11 -27%	0.1 -9%	0.06 -40%	0 N/A	0 N/A	-0.01 N/A	-0.01 N/A